Matches in Wikidata for { <http://www.wikidata.org/entity/Q64708901> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q64708901 description "clinical trial" @default.
- Q64708901 description "ensayu clínicu" @default.
- Q64708901 description "klinisch onderzoek" @default.
- Q64708901 description "клінічне випробування" @default.
- Q64708901 name "Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib" @default.
- Q64708901 type Item @default.
- Q64708901 label "Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib" @default.
- Q64708901 prefLabel "Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib" @default.
- Q64708901 P1050 Q64708901-3744DCE4-C8F7-4B71-B9E6-FAFACAC51C85 @default.
- Q64708901 P1132 Q64708901-2C4BBF01-2C87-4B8A-8D4C-69E98B40809B @default.
- Q64708901 P1476 Q64708901-F2BC016C-13D7-4FC4-B9BA-32F6DBFFEE42 @default.
- Q64708901 P17 Q64708901-09502A52-7442-4680-9C41-B3203C5AB9D1 @default.
- Q64708901 P17 Q64708901-1289F46B-02B0-4682-ABEF-46A51E987341 @default.
- Q64708901 P17 Q64708901-1AE8BEF5-EFDD-4C42-BEFA-66FB053DF7D1 @default.
- Q64708901 P17 Q64708901-3931DB6A-C44D-4490-9AE0-4C3CFB10E7E1 @default.
- Q64708901 P17 Q64708901-3AB1087B-2327-45E8-8E78-71451A83308B @default.
- Q64708901 P17 Q64708901-3DFE4536-EEB6-4463-AF9C-9BCCD29EDB72 @default.
- Q64708901 P17 Q64708901-7AA28C80-9B56-491F-A6C4-EAEDB4527C16 @default.
- Q64708901 P17 Q64708901-97A98C4C-4FF0-43C7-BF67-572A8F2EEC43 @default.
- Q64708901 P17 Q64708901-F2AC5D1E-EF2E-42CF-AE62-F31E8D986813 @default.
- Q64708901 P17 Q64708901-FE1F5CA3-0164-4671-81A6-DBAF789CA398 @default.
- Q64708901 P1813 Q64708901-5CDC95D3-00BD-4BEE-B23E-D17691AD60F2 @default.
- Q64708901 P2899 Q64708901-D034D952-9571-4AB7-B6FF-E1492702C968 @default.
- Q64708901 P3098 Q64708901-4C3F772E-CA51-4729-ABD0-EEF44EC4C1BE @default.
- Q64708901 P31 Q64708901-AFC93590-2DA4-44D8-AD0B-AAC889BB10B9 @default.
- Q64708901 P580 Q64708901-D56A9C15-5218-4E70-BD34-43D6A2C6505C @default.
- Q64708901 P582 Q64708901-710D2163-E724-4DBC-94BD-E8CDBF059EA5 @default.
- Q64708901 P6099 Q64708901-891143C0-06CD-4293-8DA2-DB9114CED307 @default.
- Q64708901 P6153 Q64708901-815F2D08-7239-408B-9EF8-7AE938160A32 @default.
- Q64708901 P8363 Q64708901-8FE79726-D9BA-4C29-9261-F00BD6210CCB @default.
- Q64708901 P859 Q64708901-39201DCC-6572-434D-BB21-D7C916182448 @default.
- Q64708901 P1050 Q29496 @default.
- Q64708901 P1132 "+191" @default.
- Q64708901 P1476 "A Randomized Phase Lll Study of Imatinib Dose Optimization Compared With Nilotinib in Patients With Chronic Myelogenous Leukemia and Suboptimal Response to Standard-dose Imatinib" @default.
- Q64708901 P17 Q155 @default.
- Q64708901 P17 Q183 @default.
- Q64708901 P17 Q36 @default.
- Q64708901 P17 Q414 @default.
- Q64708901 P17 Q668 @default.
- Q64708901 P17 Q717 @default.
- Q64708901 P17 Q739 @default.
- Q64708901 P17 Q774 @default.
- Q64708901 P17 Q804 @default.
- Q64708901 P17 Q96 @default.
- Q64708901 P1813 "LASOR" @default.
- Q64708901 P2899 "+16" @default.
- Q64708901 P3098 "NCT00802841" @default.
- Q64708901 P31 Q30612 @default.
- Q64708901 P580 "2009-05-01T00:00:00Z" @default.
- Q64708901 P582 "2014-07-01T00:00:00Z" @default.
- Q64708901 P6099 Q42824827 @default.
- Q64708901 P6153 Q507154 @default.
- Q64708901 P8363 Q78089383 @default.
- Q64708901 P859 Q507154 @default.